Indexed metadata

Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study

M J H Boumans, J G A Houbiers, P Verschueren, H Ishikura, R Westhovens, E Brouwer, B Rojkovich, S Kelly, M den Adel, J Isaacs, H Jacobs, J Gomez-Reino, G M Holtkamp, A Hastings, D M Gerlag, P P Tak

Source record

Source: Crossref

Published: Feb 1, 2012

DOI: 10.1136/annrheumdis-2011-200298

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.

Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study — Mathematical Frontier Network